“The challenges evolve. While early struggles revolved around survival and scaling, today’s landscape demands agility, a circumvention of bureaucratic hurdles, and a long-term vision unhindered by the pressure of short-term gains,” said G V Prasad, co-chairman and MD of Dr Reddy’s Laboratories (DRL). He spoke at a session, ‘Pharma’s Impact on Hyderabad,’ held as part of the recent Hyderabad Literary Festival, in the ‘Science and the City’ event.
On the concluding day of HLF, 26th Jan, 2025, Prasad participated in the session along with another prominent figure in the pharmaceutical space, Dr K Anand Kumar, Managing Director of Indian Immunologicals Limited (IIL), while the session is moderated by Deepanwita Chattopadhyay, CEO of ICICI Knowledge Park.
“We grappled with basic survival, fearing we wouldn’t be able to meet payroll,” Prasad said, candidly recounting the early days of DRL with a touch of nostalgia.
The transformation of DRL from an entrepreneurial venture to a professionally managed powerhouse represents a significant chapter in Hyderabad’s pharmaceutical account. Prasad’s narrative during the session didn’t just outline the evolution of DRL into a ₹35,000 crore behemoth but also painted a vivid picture of himself as a resilient leader who climbed the corporate ladder from the most junior position in the room to becoming the most senior.
Innovations & Ethical Practices
The session also delved into the broader impacts of pharmaceutical advancements, such as combating Anti-Microbial Resistance (AMR) and responsible manufacturing practices. Prasad emphasized the importance of the ‘One Health’ approach, which integrates human, animal, and environmental health strategies, demonstrating a commitment to holistic wellness and sustainability.
Moreover, Prasad highlighted the company’s dedication to social good. He proudly noted that the drugs and vaccines manufactured in India are not only of the highest quality but also priced among the lowest in the world, reflecting a balance between profitability and public service. This pricing strategy is crucial in making essential medicines accessible to a broader demographic, reinforcing the role of major pharmaceutical companies in global health equity.
Personal Reflections & Passions
An attendee’s personal encounter with G.V. Prasad, as shared in a LinkedIn post, further humanized this pharmaceutical magnate. Described as simple, relaxed, and effusive, Prasad’s engagement at the event went beyond professional boundaries, offering glimpses into his passion for wildlife photography and his reflective insights on personal growth and professional transitions.
The session ‘Pharma’s Impact on Hyderabad’ not only highlighted the technological and scientific achievements of Hyderabad’s pharmaceutical sector but also underscored the ethical and humane aspects of business that Prasad champions. As Hyderabad continues to emerge as a hub for pharmaceutical innovation, the insights from leaders like G.V. Prasad serve as a beacon for future enterprises, blending rigorous business strategies with a strong ethical foundation to meet the health challenges of tomorrow.
–Naresh Nunna
